PAM-treated tumor lysates showed enhanced DC maturation, increased expression of CD83, CD86, and CD40, favorable cytokine profiles (IL-12/IL-10), and reduced expression of PDL1 and ILT-4. This evidence concerns the gene CD274 and neoplasm.